David Hoel to Time Factors
This is a "connection" page, showing publications David Hoel has written about Time Factors.
Connection Strength
0.249
-
Administration of lower doses of radium-224 to ankylosing spondylitis patients results in no evidence of significant overall detriment. PLoS One. 2020; 15(4):e0232597.
Score: 0.096
-
Impact of race and baseline PSA on longitudinal PSA. Int J Cancer. 2006 Apr 01; 118(7):1773-6.
Score: 0.036
-
Biologically-based risk estimation for radiation-induced chronic myeloid leukemia. Radiat Environ Biophys. 2000 Sep; 39(3):153-9.
Score: 0.025
-
Decreasing cardiovascular disease and increasing cancer among whites in the United States from 1973 through 1987. Good news and bad news. JAMA. 1994 Feb 09; 271(6):431-7.
Score: 0.016
-
Exploring time trends in cancer incidence. Cancer Causes Control. 1992 Sep; 3(5):409-17.
Score: 0.014
-
Perspective and overview of the concepts and value of hazard identification as the initial phase of risk assessment for cancer and human health. Scand J Work Environ Health. 1992; 18 Suppl 1:83-9.
Score: 0.013
-
Exploring relationships between mutagenic and carcinogenic potencies. Mutat Res. 1988 Sep; 196(2):161-75.
Score: 0.011
-
Modeling time-to-tumor data: analysis of the ED01 study. Fundam Appl Toxicol. 1983 Sep-Oct; 3(5):458-69.
Score: 0.008
-
Statistical measures of risk. Drug Metab Rev. 1982; 13(5):829-38.
Score: 0.007
-
Animal experimentation and its relevance to man. Environ Health Perspect. 1979 Oct; 32:25-30.
Score: 0.006
-
The effect of dose on cancer latency period. J Environ Pathol Toxicol. 1977 Nov-Dec; 1(2):279-86.
Score: 0.005
-
Estimation of risks of irreversible, delayed toxicity. J Toxicol Environ Health. 1975 Sep; 1(1):133-51.
Score: 0.004
-
Estimating the generation-time distribution of an age-dependent branching process. Biometrics. 1974 Mar; 30(1):125-35.
Score: 0.004
-
Statistical analysis of survival experiments. J Natl Cancer Inst. 1972 Aug; 49(2):361-72.
Score: 0.004
-
Fundamental carcinogenic processes and their implications for low dose risk assessment. Cancer Res. 1976 Sep; 36(9 pt.1):2973-9.
Score: 0.001